Abivax Announces the Appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors - Abivax (OTC:AAVXF)

PARIS, FRANCE / ACCESSWIRE / July 11, 2023 / Abivax SA (PARIS:FR), a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the immune system to treat patients with chronic

Related Keywords

San Francisco ,California ,United States ,Ferris State University ,Michigan ,Paris ,France General ,France ,Los Angeles ,Cincor Pharma ,Juneh Lee ,Troy Ignelzi ,Kinam Hong ,Jean Jacques Bertrand ,June Lee ,Philippe Pouletty ,School Of Medicine At University California ,Remuneration Committee ,University Of California ,Genentech ,Eledon Pharmaceuticals Inc ,Audit Committee ,Astrazeneca ,School Of Medicine ,Bristol Myers Squibb ,Eli Lilly Co ,Johns Hopkins University ,Advisory Board For Johns Hopkins University Center ,Catalyst Program ,Euronext ,Translational Research ,Abivax Board ,Joy Amundson ,Sofinnova Partners ,Truffle Capital ,Venture Partner ,Executive Vice President ,Chief Development Officer ,Chief Operating Officer ,Tenaya Therapeutics ,Eledon Pharmaceuticals ,Scientific Advisory Board ,Advisory Board ,Johns Hopkins University Center ,Therapeutic Translation ,Cincor Therapeutics ,Karuna Therapeutics ,Esperion Therapeutics ,Insys Therapeutics ,Eli Lilly ,Vedanta Biosciences ,Big Rapids ,